Blog

You are here

17
May

Queensland researchers develop direct-acting antiviral to treat COVID-19

A team of Australian and US scientists from Menzies Health Institute Queensland (MHIQ) at Griffith University and from US research institute City of Hope, has developed an experimental direct-acting antiviral therapy to treat COVID-19. Lead researcher Professor Nigel McMillan from MHIQ said: "It causes the genome to be destroyed and the virus can't grow anymore. So we inject the nanoparticles and they go and find the virus and destroy it just like a heat-seeking missile."

13
May

Jab-free dengue immunity could be just a click away

A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year. The University of Queensland-developed vaccine candidate, applied to the skin via the high-density microarray patch (HD-MAP), has produced a protective immune response in dengue-infected mice.

12
May

New Qld study - More nurses lead to fewer patient deaths and readmissions, shorter hospital stays, and savings

A study across 55 Queensland hospitals suggests that a recent state policy to introduce a minimum ratio of one nurse to four patients for day shifts has successfully improved patient care, with a 7% drop in the chance of death and readmission, and 3% reduction in length of stay for every one less patient a nurse has on their workload.

10
May

New Australian pregnancy physical activity guidelines recommended

A set of physical activity for pregnancy guidelines, developed by The University of Queensland and CQUniversity, was released by the Australian Government Department of Health on Mother's Day.

7
May

Replacing IV infusion sets in hospital patients weekly does not increase infection risk

Australian researchers hope to save significant time, money and resources in hospital wards, with findings from a new University of Queensland-led study published in The Lancet.

22
Apr

Long COVID/Post-Acute COVID-19 Syndrome (PACS) a punch

A significant proportion of patients who recovered from acute COVID-19 illness are now reporting post-acute COVID-19 syndrome (PACS), a lingering ailment also known as “long COVID” or “post-COVID syndrome”. Patients with post-acute COVID-19 syndrome generally experience COVID-like symptoms lasting weeks after their acute COVID-19 illness. Symptoms include fatigue, joint pain, chest pain, palpitations, shortness of breath, as well as some neurologic and psychiatric manifestations including anxiety, headache, loss of taste or smell, and cognitive impairment (i.e. “brain fog”). These symptoms are vague and difficult to quantify, making unbiased study of this syndrome a challenge.

20
Apr

Monash University researchers find a way to mend a broken heart

A Monash University study has uncovered for the first time a way to prevent and reverse damage caused by broken-heart syndrome, also known as Takotsubo cardiomyopathy.

16
Apr

Adenovirus-vectored vaccines for COVID-19 – how do they work?

While safety concerns have dominated the recent discussion about the AstraZeneca and Johnson & Johnson vaccines, it’s useful to understand the mechanisms behind these types of adenovirus-vectored vaccines that have been in use since the 1950s.

16
Apr

New universal hydrogel can repair tears in human tissue

Soft tissues can be easily torn resulting from sporting injuries or through various accidents. Binding the tissue back together can prove problematic for surgeons, as stitches often do more harm than good. Swiss scientists have developed an injectable gel that can attach to various kinds of soft internal tissues and repair tears resulting from an accident or trauma.

14
Apr

Suicide among female nurses is double that of the general female population

Female nurses are roughly twice as likely to commit suicide than the general female population and 70% more likely than female doctors, according to a US study examining suicide among physicians and nurses.

Pages